抑制 HDAC3（组蛋白去乙酰化酶 3）异常和由此产生的 Nrf2（核因子红细胞衍生 2 相关因子 2）抑制可减轻肺纤维化。

1

Hypertension. 2021 Aug;78(2):e15-e25. doi: 10.1161/HYPERTENSIONAHA.121.17471. Epub 2021 Jun 21.

2

Respir Res. 2010 Mar 18;11(1):31. doi: 10.1186/1465-9921-11-31.

3

Mol Med Rep. 2017 Jun;15(6):4005-4014. doi: 10.3892/mmr.2017.6546. Epub 2017 May 3.

4

Free Radic Biol Med. 2017 Nov;112:578-586. doi: 10.1016/j.freeradbiomed.2017.08.026. Epub 2017 Sep 1.

5

Am J Chin Med. 2019;47(5):1113-1131. doi: 10.1142/S0192415X19500575. Epub 2019 Jul 29.

6

Antioxid Redox Signal. 2019 May 20;30(15):1831-1848. doi: 10.1089/ars.2018.7569. Epub 2018 Sep 22.

7

Mol Cell. 2014 Mar 20;53(6):916-928. doi: 10.1016/j.molcel.2014.01.033. Epub 2014 Mar 6.

8

Toxicol Lett. 2013 Jun 20;220(1):15-25. doi: 10.1016/j.toxlet.2013.03.034. Epub 2013 Apr 6.

9

Immunopharmacol Immunotoxicol. 2020 Oct;42(5):436-444. doi: 10.1080/08923973.2020.1806871. Epub 2020 Aug 29.

10

Free Radic Biol Med. 2018 Dec;129:446-453. doi: 10.1016/j.freeradbiomed.2018.10.423. Epub 2018 Oct 16.

Inhibiting HDAC3 (Histone Deacetylase 3) Aberration and the Resultant Nrf2 (Nuclear Factor Erythroid-Derived 2-Related Factor-2) Repression Mitigates Pulmonary Fibrosis.